Healthcare Finance News October 17, 2022
The administration will task HHS and CMMI with testing new models that are shown to improve quality and lower costs.
President Biden has issued an executive order detailing new payment and delivery models intended to lower the prices of prescription drugs, focusing on models that can be tested under the Center for Medicare and Medicaid Innovation.
The order follows August’s passage of the Inflation Reduction Act of 2022, which was intended to protect beneficiaries from high drug costs by phasing in a cap for out-of-pocket costs at the pharmacy, and establishing a $35 monthly cap per prescription for insulin covered by a Medicare prescription drug plan, as well as insulin delivered through traditional pumps.
Beginning in January, Medicare beneficiaries with...
Today's Sponsors
Today's Sponsor